Curbside Consult: Fibromyalgia
The 2009 American College of Rheumatology/Association of Rheumatology Health Professionals Scientific Meeting will feature several “Curbside Consult/Ask the Professors” sessions. Designed to feature information and discussion about “difficult management decisions that must be made in the absence of strong data,” these sessions give attendees the opportunity to “compare their personal management approaches” to the clinical problems outlined in the featured vignettes and scenarios with those of “the academic expert consultants and other clinicians in the audience.”
It's Not All in the Mind: Cognitive Function and Fibromyalgia
The Monday morning sessions at the 2009 American College of Rheumatology/Association of Rheumatology Health Professionals featured several presentations that focused on cognitive functioning in fibromyalgia and lupus.
What's the Best Way to Treat Fibromyalgia? A Holistic Approach
Fibromyalgia is a complex illness, especially when there are some healthcare professionals who do not consider it to be an illness. However, there is a high prevalence of fibromyalgia (3-4.7% of the general population) and patients who have it experience poor quality of life and place a high economic burden on themselves, their families, and society.
People with RA Not at Increased Risk of Serious Infection with Biologic Therapy
October 18th 2009The most important risk factors for serious infections were not biologic medications, as some might have expected, but instead were age, medical conditions such as emphysema, and RA-specific factors like disease duration.
How Can I Help?: Streamlining Call Management
The impetus for Alfred I. DuPont Hospital for Children’s switch to a centralized system came about because the hospital administrators wanted patients communicating with live people. An admirable goal for sure, but with only two live people available to take calls at anyone time, patients often ended up spending 15 minutes on hold waiting for a human voice, becoming frustrated and hanging up.
Glucosamine May Not Aid Osteoarthritic Knees
October 17th 2009Prior studies of glucosamine and its role in the prevention of joint damage in knee OA have produced conflicting results, but a recent study found that the odds of worsening cartilage damage in a glucosamine group were the same as for patients given a placebo.
Anti-TNF Therapy for Rheumatoid Arthritis May Increase Risk of Joint Infections
October 17th 2009Anti tumor necrosis factor therapy for rheumatoid arthritis appears to increase a patient's risk of developing septic arthritis, which is the infection of a joint, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Philadelphia, PA.
Adverse Reactions to Infusion Therapy
In a session that focused on potential adverse reactions to rheumatologic infusion therapies, Jacqueline M. Fritz, RN, MSN, CNS, Arthritis and Osteoporosis, La Palma, California, explained that infusion therapies take time to administer.